Modification of Hyaluronan by Heavy Chains of Inter-α-Inhibitor in Idiopathic Pulmonary Arterial Hypertension

Elevated Plasma Hyaluronan Levels in Pulmonary Hypertension

(2013) Nihat Kalay et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Modern Age Pathology of Pulmonary Arterial Hypertension

(2012) Elvira Stacher et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Inflammation in Pulmonary Arterial Hypertension

(2012) Laura C. Price et al.   CHEST

Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Amplifies Hyaluronan Synthesis by Airway Smooth Muscle Cells

(2012) Mark E. Lauer et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CD44 expression in plexiform lesions of idiopathic pulmonary arterial hypertension

(2012) Keiko Ohta-Ogo et al.   PATHOLOGY INTERNATIONAL

Immune and inflammatory mechanisms in pulmonary arterial hypertension

(2012) Hala El Chami et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-α antagonists via the suppression of TNF-α expression and NF-κB pathway in rats

(2012) Qiang Wang et al.   VASCULAR PHARMACOLOGY

Hyaluronan matrices in pathobiological processes

(2011) Aimin Wang et al.   FEBS Journal

High levels of hyaluronan in idiopathic pulmonary arterial hypertension

(2008) Metin Aytekin et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY